MDHI news is out!
KING OF PRUSSIA, Pa., March 4, 2013 /PRNewswire/ -- Medical Alarm Concepts Holding, Inc. (OTCPink: MDHI), today provided details about its recently accelerating growth rate and a contract signed with a diversified national insurer where Medical Alarm Concepts will become a provider of personal medical alarms.
Under the terms of the new agreement, the diversified national insurer will offer the Company's MediPendant® product and monthly monitoring services to subscribers of selected healthcare programs. Additionally, the Company's MediPendant® product has been, or may be, included in their dual demonstration program (Medicare and Medicaid) related contracts on which they may bid. Additional information regarding this contract can be viewed on the website hosted by the US Securities & Exchange Commission at the following link:
www.sec.gov/Archives/edgar/data/1443089/000147124213000073/mdhifeb262013.htm
Mr. Ronnie Adams commented, "We are expecting this contract to generate growth in revenues and earnings. As a result of gaining this contract, we plan to expand our business operations in the areas of manufacturing, financial management, research and development, and logistics."
Over the past few months Medical Alarm Concepts has been experiencing strong growth in revenues due to an expanding retail presence, strong Internet sales and new international opportunities. Having now reached operational cash flow profitability, the Company is expecting to report positive cash flow for the full quarter ending March 31, 2013 and throughout calendar 2013.
"We are very pleased that our cash flow will be based on very high quality recurring revenues. Our retail partnerships remain strong. This week we began the first of two promotions that are scheduled for the late winter and early spring period. Thus far, sales have been extremely robust, which is strongly adding to our recurring monthly revenue base. We are expecting calendar 2013 to be a year of very strong growth and cash flow," said Mr. Ronnie Adams.
The MediPendant® is a second-generation personal medical alarm and the only product in its category that allows for monitored, two-way communications directly through the pendant along with patented voice prompts. Older generations of technology require the user to be in close proximity to the base station in order to speak and listen to the operator. With the MediPendant®, the customer can be anywhere within approximately 600 feet of their home and in the event of an emergency, speak and listen to the EMT trained operator directly through the pendant.
Additional information on the MediPendant® can be viewed at www.MediPendant.com.
About MDHI
Medical Alarm Concepts Holdings, Inc. (MAC) develops and manufactures innovative products and practical solutions within the framework of a vast growing marketplace. MediPendant's® patented two-way voice technology enables the user to speak and listen directly through the pendant no matter where the user may be in and around their home. MediPendant® service also includes advanced features such as three-way calling that enables the operator to link loved ones directly into the emergency call in real time. Text message alerts are also standard, and are used to inform loved ones that the user has contacted an operator or has requested assistance. A standard PERS system does not enable the user to speak and listen through the pendant, thus limiting them to a small area in their home. There is always the risk that the user will not be heard by the call center operator if they are not within a short range of the base station.
MDHI news is out! KING OF PRUSSIA, Pa., March 4, 2013
Top 10 Most Recent News Articles
Radiofrequency Microneedling: A Fresh Skin Solution?
Vet the Process Before Diving In Everyone wants to turn back the clock on their skin, but it's crucial to know what you're getting into. This ain't a quick splash of water on the face; it's radiofrequency microneedling we're talking about. And honey, it’s no fairy tale—it’s science, plain and simple. Drilling Down on Microneedling This procedure, preached by Dr....
Continue Reading
Purina's Docuseries Wins Big at Daytime Emmys
Unleashing a Winning Streak Forget stock price fluctuations—Purina Films has struck gold. In a world where brand stories often fall flat or feel contrived, Purina's 'A Different Breed' docuseries just bagged three Daytime Emmy® Awards. It's not every day you see corporate storytelling make a splash like this, but when you blend pets and riveting narratives, magic...
Continue Reading
Flash Tech Sparks New Era in Gas Sensing
Revolutionary 10-Millisecond Flash Technique Out of South Korea comes a scientific shake-up that's got eyes on a tiny flash of light poised to change gas sensing technology as we know it. Yep, at Hanyang University ERICA, the boffins have figured out how a quick-fire 10-millisecond zap can turn up the sensitivity dial on gas sensors, especially for the pesky nitrogen...
Continue Reading
KickHouse Partners with Sam Alvey for Glove Line Launch
KickHouse Pounces with New Fighter Partnership Looks like KickHouse isn't playing games, folks. They've teamed up with fighter Sam Alvey to launch a new boxing glove line. You got your Warbird, your Desert Ghost, and your Night Ops gloves—names straight out of a war zone. These 16-ounce hammers are out now, and they kickstart a broader gear lineup custom-built for Alvey...
Continue Reading
BioArctic's Moves: Lecanemab Data and Leadership Insights
BioArctic's Power Play: A Two-Pronged Update Ever feel like biotechnology is just a series of chess moves? BioArctic's recent maneuvers in the life sciences game certainly hint at that. First, they've got data brewing on lecanemab—this ain't small beans, folks, not with Alzheimer's disease in the crosshairs. Then there's their Nomination Committee. It’s like shaking...
Continue Reading
Ping Identity Tops 2026 Gartner Magic Quadrant: CIAM
Turning Heads in the Cybersecurity Space When it comes to digital security, Ping Identity has snagged a top spot in Gartner's 2026 Magic Quadrant for Customer Identity and Access Management (CIAM). Some might gloss over these annual reports like yesterday's news, but Ping isn't just playing around here. They've been tapped as a Leader again, and this accolade highlights...
Continue Reading
Glance's Guide Bridges AI and Human Service Gaps
Untangling the AI to Human Transition Ever found yourself stuck in a never-ending loop with AI, screaming for a human voice? You're not alone. According to Glance's 2026 Customer Experience Trends Report, a staggering 76% of consumers are pulling their hair out while repeating themselves when switching service channels. The rub? Only 7% claim they rarely experience this...
Continue Reading
Holiday Shoppers Eye Payment Options Amid Tight Budgets
Shoppers Feel the Squeeze As Holidays Approach Hope you brought your umbrella because the holiday season is going to be awash with financial strain and stress for many consumers. According to the latest ETA-TSG Consumer Holiday Spending Study, 44% of consumers are more financially stressed this year compared to last, and the numbers aren't getting any rosier from there....
Continue Reading
Winter Travel Booms: Top Destinations Unveiled for 2026
Winter Travel Surge: Rising Demand for Top Destinations Every year as the temperature drops, the excitement for winter travel heats up, and this season's no different. Booking patterns confirm that while people are dreaming of holiday magic, they're also gunning for sun when cold's on the horizon. New York City's holiday glitz leads the domestic charge, backed by a power...
Continue Reading
Orbis International to Boost Global Eye Health Efforts
Pledge for Vision In a world where a staggering number of folks wrestle with avoidable vision issues, Orbis International is stepping up to the plate with ambitions that feel as bold as they are necessary. Orbis is pouring a significant $32 million into its mission to beef up eye health systems, train a small army of professionals, and apply AI in eye care. Their big bet...
Continue ReadingTop 5 Most Recently Viewed Articles
Exciting Developments in Titanium Powder Production by PyroGenesis
Significant Contract for Titanium Powder Production PyroGenesis Inc., a pioneer in ultra-high temperature processes and a leading technology provider to heavy industry and defense, is making waves in the additive manufacturing sector. The company has announced an initial order for 'fine cut' titanium powder, which has been produced using their advanced NexGen™ plasma...
Continue Reading
Exploring The Impressive Returns of The Hartford Insurance
Understanding The Hartford Insurance Group's Growth The Hartford Insurance Group (NYSE: HIG) has displayed impressive market performance over the past five years, outpacing overall market gains significantly. With an annualized return of 26.43%, this company has offered a noteworthy 12.44% lead over the market average. Current market capitalization stands at approximately...
Continue Reading
Exciting New Consumer Product Launches and Trends This Week
Highlights of this Week’s Major Consumer Announcements This week brings an exciting selection of consumer and retail news that you won’t want to miss. From the world of fragrances to the latest Halloween trends, here’s a closer look at some captivating announcements that are making waves. Ariana Grande’s Wicked-Inspired Fragrances Ariana Grande has taken things to...
Continue Reading
Occidental Petroleum's Significant Debt Reduction Achievements
Occidental Petroleum's Debt Reduction Strategy In a significant stride towards enhancing its financial health, Occidental Petroleum (NYSE: OXY) announced remarkable progress in its debt reduction efforts, achieving a key target of $4.5 billion by the end of 2024. This noteworthy milestone positions the company well as it navigates the complexities of the evolving energy...
Continue Reading
Aptose Unveils Promising New Therapy for AML Patients
Aptose Unveils Promising New Therapy for AML Patients In a groundbreaking development, Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS) recently announced that the initial patients have been dosed in the TUSCANY Phase 1/2 trial. This innovative trial evaluates the effectiveness of tuspetinib (TUS) in combination with venetoclax (VEN) and azacitidine (AZA). This trio...
Continue Reading